Rise in gamma interferon expression during resolution of duck hepatitis B virus infection

Journal of General Virology

Volumn 87, Issue 11, 2006, Pages 3225-3232

  Narayan, Ramamurthy ^a   Buronfosse, Thierry ^a,b   Schultz, Ursula ^c   Chevallier Gueyron, Philippe ^d   Guerret, Sylviane ^e   Chevallier, Michelle ^f   Saade, Fadi ^a   Ndeboko, Benedicte ^a   Trepo, Christian ^a   Zoulim, Fabien ^a   Cova, Lucyna ^a  

^a INSERM   (France)

^b VETAGRO SUP   (France)

^c UNIVERSITY OF FREIBURG   (Germany)

^d HOSPICES CIVILS DE LYON   (France)

^e Novotec   (France)

^f Pathology Department   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PRES PROTEIN; RNA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DUCK; FOLLOW UP; HEPATITIS B; HISTOPATHOLOGY; HUMORAL IMMUNITY; INFECTION; INFECTION CONTROL; LIVER; LYMPHOCYTIC INFILTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANAS; ANIMALIA; DUCK HEPATITIS B VIRUS; HEPADNAVIRIDAE; HEPATITIS B VIRUS; MAMMALIA;

EID: 33750282045     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82170-0     Document Type: Article

References (28)

1. Abel, K., Alegria-Hartman, M. J., Zanotto, K., McChesney, M. B., Marthas, M. L. & Miller, C. J. (2001). Anatomic site and immune function correlate with relative cytokine mRNA expression levels in lymphoid tissues of normal rhesus macaques. Cytokine 16, 191-204.
2. Abel, K., La Franco-Scheuch, L., Rourke, T., Me, Z.-M., de Silva, V., Fallert, B., Beckett, L., Reinhart, T. A. & Miller, C. J. (2004). Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. J Virol 78, 841-854.
3. Barraud, L., Guerret, S., Chevallier, M., Borel, C., Jamard, C., Trepo, C., Wild, C. P. & Cova, L. (1999). Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure. Hepatology 29, 1317-1323.
4. Cavanaugh, V. J., Guidotti, L. G. & Chisari, F. V. (1998). Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol 72, 2630-2637.
5. Chassot, S., Lambert, V., Kay, A., Godinot, C., Trepo, C. & Cova, L. (1994). Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning. Virology 200, 72-78.
6. Cova, L. & Zoulim, F. (2004). Duck hepatitis B virus model in the study of hepatitis B virus. Methods Mol Med 96, 261-268.
7. Guidotti, L. G. & Chisari, F. V. (2001). Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19, 65-91.
8. Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R. & Chisari, F. V. (1999). Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825-829.
9. Hodgson, P. D. & Michalak, T. (2001). Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 34, 1049-1059.
10. Jilbert, A. R., Wu, T.-T., England, J. M., Hall, P. da la M., Carp, N. Z., O'Connell, A. P. & Mason, W. S. (1992). Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 66, 1377-1388.
11. Jilbert, A. R., Botten, J. A., Miller, D. S., Bertram, E. M., Hall, P. de la M., Kotlarski, J. & Burrell, C. J. (1998). Characterization of age- and dose-related outcomes of duck hepatitis B virus infection. Virology 244, 273-282.
12. Klöcker, U., Schultz, U., Schaller, H. & Protzer, U. (2000). Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication. J Virol 74, 5525-5533.
13. Le Guerhier, F., Thermet, A., Guerret, S., Chevallier, M., Jamard, C., Gibbs, C. S., Trépo, C., Cova, L. & Zoulim, F. (2003). Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model. J Hepatol 38, 328-334.
14. Le Mire, M. F., Miller, D. S., Foster, W. K., Burrell, C. J. & Jilbert, A. R. (2005). Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection. J Virol 79, 12242-12252.
15. Menne, S., Wang, Y., Butler, S. D., Gerin, J. L., Cote, P. J. & Tennant, B. C. (2002). Real-time polymerase chain reaction assays for leukocyte CD and cytokine mRNAs of the Eastern woodchuck (Marmota monax). Vet Immunol Immunopathol 87, 97-105.
16. Rehermann, B. & Nascimbeni, M. (2005). Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5, 215-229.
17. Rehermann, B., Ferrari, C., Pasquinelli, C. & Chisari, F. V. (1996). The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2, 1104-1108.
18. Rollier, C., Sunyach, C., Barraud, L., Madani, N., Jamard, C., Trepo, C. & Cova, L. (1999). Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology 116, 658-665.
19. Rollier, C., Charollois, C., Jamard, C., Trepo, C. & Cova, L. (2000). Early life humoral response of ducks to DNA immunization against hepadnavirus large envelope protein. Vaccine 18, 3091-3096.
20. Schultz, U. & Chisari, F. V. (1999). Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J Virol 73, 3162-3168.
21. Seignères, B., Martin, P., Werle, B., Schorr, O., Jamard, C., Rimsky, L., Trepo, C. & Zoulim, F. (2003). Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model. Antimicrob Agents Chemother 47, 1842-1852.
22. Sunyach, C., Rollier, C., Robaczewska, M., Borel, C., Barraud, L., Kay, A., Trepo, C., Will, H. & Cova, L. (1999). Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction. J Virol 73, 2569-2575.
23. Thermet A., Rollier, C., Zoulim, F., Trepo, C. & Cova, L. (2003). Progress in DNA vaccine for prophylaxis and therapy of hepatitis B. Vaccine 21, 659-662.
24. Urban, S., Schwarz, C., Marx, U. C., Zentgraf, H., Schaller, H. & Multhaup, G. (2000). Receptor recognition by a hepatitis B virus reveals a novel mode of high affinity virus-receptor interaction. EMBO J 19, 1217-1227.
25. Vickery, K., Cossart, Y., Gu, X. & Dixon, R. (1997). Antigen-specific blastogenesis assays for duck hepatitis B virus using duck peripheral blood and splenic mononuclear cells. Vet Immunol Immunopathol 59, 349-358.
26. Wieland, S. F. & Chisarl, F. V. (2005). Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79, 9369-9380.
27. Wieland, S. F., Spangenberg, H. C., Thimme, R., Purcell, R. H. & Chisari, F. V. (2004). Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci U S A 101, 2129-2134.
28. Zhang, Y.-Y. & Summers, J. (2004). Rapid production of neutralizing antibody levels leads to transient hepadnavirus infection. J Virol 78, 1195-1201.